Pharmacovigilance – News and Features

The project lead by Iongate involves quantitative analysis that can facilitate the description of dynamic processes in living systems.

Vanderbilt University Medical Center and the National Foundation for Cancer Research have established a cancer research center from $1 million funded by NFCR.

Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.

Serono will use Genedata’s computational solution to combine results from HCS assays with chemical and pharmacological information to identify promising drug candidates.

A multidisciplinary Purdue research team will lead one of eight national nanomedicine development centers.

ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke.

InnoMed PredTox is a joint industry, academic and European Commission collaboration to improve drug safety testing.

SR Pharma has announced that studies have demonstrated the therapeutic efficacy of Atu027 RNAi in pre-clinical models of pancreatic cancer.

The technique offers new possibilities for matching drug treatments more closely to patient needs.

DNA tests could prevent thousands of emergency room visits, hospitalizations and deaths for warfarin patients.